Plantify Foods Reports Resumption to Trading

Executive Summary

• The TSX Venture Exchange has indicated that Plantify Foods, Inc. will resume trading of its common shares.
• As of October 31 2025 the company reported a working‑capital deficiency of approximately $850,000 and intends to seek one or more financings to remedy this shortfall.
• The company does not meet TSXV’s asset and operations (“CLR”) requirements; if it cannot secure a qualifying business within ~90 days, its securities may be transferred to the NEX market.

Key Details

• Trading Resumption: TSX Venture Exchange advised that Plantify’s common shares will resume trading (previously halted).
• Working‑Capital Deficiency: $850 k shortfall as of 31 Oct 2025.
• Financing Plans: Management intends to pursue one or more financings; no guarantee such financing will be available or on acceptable terms.
• CLR Non‑Compliance: Company currently lacks a business and therefore does not satisfy TSXV asset/operations criteria.
• Potential Delisting Risk: If no qualifying business is identified within roughly 90 days, the securities may be moved to the NEX market.
• Debenture Conversion Issue: Following an August 22 2025 release, the company was unable to obtain TSXV approval to extend the conversion feature of $240 k aggregate principal debentures because trading was halted; consequently, those debentures are no longer convertible into common shares.

Notable Quotes

• None provided in the release.